ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,694Medicare Part D Prescriptions Filled, Including Refills

Rank: 23 out of 1448

$704K Total Retail Price of All Prescriptions

Rank: 63 out of 1448

633 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 633 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

27% of this provider’s 633 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

5% of this provider’s 13,942 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
HYDROCODONE-ACETAMINOPHEN 801 584 S3 1 33
FUROSEMIDE 641 505 2 7
LISINOPRIL 623 570 3 5
ATENOLOL 507 425 4 12
HYDROCHLOROTHIAZIDE 458 407 5 18
LOVASTATIN 396 363 6 35
LEVOTHYROXINE SODIUM 393 328 7 21
OMEPRAZOLE 351 307 8 23
POTASSIUM CHLORIDE 343 274 9 19
SIMVASTATIN 340 294 10 3
CARVEDILOL 323 270 11 1
WARFARIN SODIUM 310 262 12 8
METFORMIN HCL 289 243 13 25
AMLODIPINE BESYLATE 270 238 14 2
GABAPENTIN 264 201 15 51
METOPROLOL TARTRATE 261 210 16 9
NIFEDIPINE ER 248 204 17 59
ALLOPURINOL 209 170 18 43
CLONIDINE HCL 192 140 19 45
ZOLPIDEM TARTRATE 186 128 20 34
GLIPIZIDE 169 149 21 75
FELODIPINE ER 167 165 22 133
GLYBURIDE 161 139 R 23 89
PANTOPRAZOLE SODIUM 161 107 23 42
IBUPROFEN 158 98 25 85
DONEPEZIL HCL 147 147 26 68
AMIODARONE HCL 144 124 27 22
DIGOXIN 136 97 28 13
ATORVASTATIN CALCIUM 135 130 29 4
ENALAPRIL MALEATE 132 107 30 48
PAROXETINE HCL 130 90 31 121
TAMSULOSIN HCL 129 115 32 46
TERAZOSIN HCL 128 124 33 116
DICLOFENAC SODIUM 121 109 34 171
CLOPIDOGREL 120 94 35 10
AZITHROMYCIN 118 102 36 76
PREDNISONE 113 83 37 110
TRIAMTERENE-HCTZ 111 111 38 55
CIPROFLOXACIN HCL 110 95 39 137
OXYBUTYNIN CHLORIDE 110 102 39 210
ISOSORBIDE MONONITRATE ER 109 109 41 16
LANTUS 106 82 42 111
AMITRIPTYLINE HCL 104 95 R 43 153
TRAMADOL HCL 101 92 44 56
BENAZEPRIL HCL 97 90 45 26
TRAZODONE HCL 89 78 46 128
CARISOPRODOL 85 60 R 47 176
PLAVIX 83 71 48 14
DOXAZOSIN MESYLATE 81 76 49 65
FLUTICASONE PROPIONATE 78 59 50 130
DILTIAZEM ER 78 68 50 78
BUPROPION HCL 78 61 50 342
PROAIR HFA 77 64 53 104
NIFEDIAC CC 76 74 54 206
LISINOPRIL-HYDROCHLOROTHIAZIDE 74 73 55 79
FINASTERIDE 73 69 56 141
MEGESTROL ACETATE 72 72 R 57 126
DILTIAZEM 24HR CD 71 68 58 61
CILOSTAZOL 66 40 59 95
METOLAZONE 65 55 60 124
CEPHALEXIN 65 55 60 138
NAMENDA 64 64 62 93
NAPROXEN 62 47 63 112
TICLOPIDINE HCL 62 62 R 63 363
RANITIDINE HCL 61 44 65 109
INSULIN SYRINGE 61 52 65 139
KETOCONAZOLE 60 47 67 204
CAPTOPRIL 59 50 68 115
ESTRADIOL 58 50 R 69 198
CYCLOBENZAPRINE HCL 55 42 R 70 214
SERTRALINE HCL 54 37 71 99
TRIAMCINOLONE ACETONIDE 54 49 71 96
KLOR-CON 10 53 47 73 102
LEVOXYL 52 52 74 213
SPIRONOLACTONE 51 24 75 24
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 11, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.